货号 | HT073026 |
---|---|
品牌 | abinScience |
种属反应性 | Human |
应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
宿主 | Humanized |
同种型 | human IgG1 - kappa - lambda with half-IG VL-CH1/VH-CK crossover |
表达系统 | Mammalian Cells |
克隆类型 | Monoclonal |
靶标 | Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A, ANG-2, ANGPT2, Angiopoietin-2 |
内毒素水平 | Please contact the lab for this information. |
纯度 | >95% purity as determined by SDS-PAGE. |
纯化方式 | Protein A/G purified from cell culture supernatant. |
Accession号 | P15692 & O15123 |
状态 | Liquid |
保存溶液 | 0.01M PBS, pH 7.4. |
稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
别名 | Bispecific, RG-7221, RG7221, RO5520985, 1448221-05-3 |
背景 | Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and angiopoietin-2 (Ang-2) from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects. |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Detects Human VEGFA in indirect ELISAs.
SEC-HPLC detection for Research Grade Vanucizumab.
Detects Human ANGPT2 in indirect ELISAs.
24小时产品查询
扫一扫关注我们
专属渠道经理